Nicotinamide Riboside Improves Ataxia Scores and Immunoglobulin Levels in Ataxia Telangiectasia

BACKGROUND: Treatment of animal models with ataxia telangiectasia (A‐T) with nicotinamide riboside (NR) improved their neurological outcome and survival. OBJECTIVE: The aim of this study is to investigate the effects of NR in patients with A‐T. METHODS: In this open‐label, proof‐of‐concept study, 24...

Descripción completa

Detalles Bibliográficos
Autores principales: Veenhuis, Stefanie J.G., van Os, Nienke J.H., Janssen, Anjo J.W.M., van Gerven, Marjo H.J.C., Coene, Karlien L.M., Engelke, Udo. F.H., Wevers, Ron A., Tinnevelt, Gerjen H., ter Heine, Rob, van de Warrenburg, Bart P.C., Weemaes, Corry M.R., Roeleveld, Nel, Willemsen, Michèl A.A.P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Regular Issue Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9291897/
https://www.ncbi.nlm.nih.gov/pubmed/34515380
http://dx.doi.org/10.1002/mds.28788

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9291897/
https://www.ncbi.nlm.nih.gov/pubmed/34515380
http://dx.doi.org/10.1002/mds.28788

Ejemplares similares